# Biosimilar Versus Urinary Gonadotropins

> **NCT02503605** · PHASE4 · UNKNOWN · sponsor: **IVI Madrid** · enrollment: 130 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Biosimilar recombinant FSH
- **DRUG:** Urinary FSH

## Key facts

- **NCT ID:** NCT02503605
- **Lead sponsor:** IVI Madrid
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2016-03
- **Final completion:** 2016-06
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2015-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02503605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02503605, "Biosimilar Versus Urinary Gonadotropins". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT02503605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*